Form 8-K - Current report:
SEC Accession No. 0001683168-25-000612
Filing Date
2025-01-30
Accepted
2025-01-30 16:02:14
Documents
16
Period of Report
2025-01-29
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT acon_8k.htm   iXBRL 8-K 40325
2 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATIO acon_ex0301.htm EX-3.1 9229
3 GRAPHIC image_001.jpg GRAPHIC 70447
  Complete submission text file 0001683168-25-000612.txt   372371

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE acon-20250129.xsd EX-101.SCH 3788
5 XBRL DEFINITION FILE acon-20250129_def.xml EX-101.DEF 26648
6 XBRL LABEL FILE acon-20250129_lab.xml EX-101.LAB 36765
7 XBRL PRESENTATION FILE acon-20250129_pre.xml EX-101.PRE 25272
18 EXTRACTED XBRL INSTANCE DOCUMENT acon_8k_htm.xml XML 5911
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 25573575
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)